Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;37(10):1025-1034.
doi: 10.1007/s10654-022-00915-z. Epub 2022 Sep 20.

Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care

Affiliations

Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care

Marcus Ebeling et al. Eur J Epidemiol. 2022 Oct.

Abstract

The Covid-19 pandemic has not affected the population evenly. This must be acknowledged when it comes to understanding the Covid-19 death toll and answering the question of how many life years have been lost. We use level of geriatric care to account for variation in remaining life expectancy among individuals that died during 2020. Based on a linkage of administrative registers, we estimate remaining life expectancy stratified by age, sex, and care status using an incidence-based multistate model and analyze the number of years of life lost (YLL) during 2020 in Sweden. Our results show that remaining life expectancy between individuals with and without care differs substantially. More than half of all Covid-19 deaths had a remaining life expectancy lower than 4 years. Yet, in a 1-year perspective, Covid-19 did not seem to replace other causes of death. Not considering the differences in remaining life expectancy in the affected populations overestimated YLL by 40% for women and 30% for men, or around 2 years per death. While the unadjusted YLL from Covid-19 amounted to an average of 7.5 years for women and 8.6 years for men, the corresponding YLL adjusted for care status were 5.4 and 6.6, respectively. The total number of YLL to Covid-19 in 2020 is comparable to YLL from ischemic heart disease in 2019 and 2020. Our results urge the use of subgroup specific mortality when counting the burden of Covid-19. YLL are considerably reduced when the varying susceptibility for death is considered, but even if most lifespans were cut in the last years of life, the YLL are still substantial.

Keywords: Care home; Covid-19; Excess deaths; Life expectancy; Multistate model; Years of life lost.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Life expectancy by care status and for the total population at different ages, women and men, Sweden, 2018–2019
Fig. 2
Fig. 2
Distribution of deaths by age and care status separately for excess deaths and deaths with Covid-19 as underlying cause of death, men and women, 2020
Fig. 3
Fig. 3
Distribution of deaths by remaining life expectancy and care status separately for excess deaths and deaths with Covid-19 as underlying cause of death, men and women, 2020 Notes: For deaths below age 70, where information on care status was unavailable, life expectancy for the total population was also used in the care-adjusted calculations for the total YLL
Fig. 4
Fig. 4
YLL for different causes of death in 2019 and 2020 and YLL from Covid-19 as underlying cause of death and excess mortality in 2020, ages 70+ , men and women Notes: Causes of death groups include infectious & parasitic diseases (ICD-10: A, B), colorectal cancer (C18–C21), ischemic heart disease (I20–I25), stroke (I60-I64), respiratory diseases (J), external causes of death (V, W, X, Y)

Similar articles

Cited by

References

    1. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021;49:15–28. doi: 10.1007/s15010-020-01509-1. - DOI - PMC - PubMed
    1. Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428–455. doi: 10.1111/all.14657. - DOI - PubMed
    1. Modig K, Lambe M, Ahlbom A, Ebeling M. Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: a population-based study. Lancet Reg Health Eur. 2021;4:100072. doi: 10.1016/j.lanepe.2021.100072. - DOI - PMC - PubMed
    1. Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584:257–261. doi: 10.1038/s41586-020-2405-7. - DOI - PubMed
    1. Kampf G, Kulldorff M. Calling for benefit-risk evaluations of COVID-19 control measures. Lancet. 2021;397:576–577. doi: 10.1016/S0140-6736(21)00193-8. - DOI - PMC - PubMed